As CKD advances, increased exposure to uremic toxins can lead to the overexpression of tissue inhibitors of osteopontin, transforming growth factor beta 1(TGF-β1), metalloproteinase 1, and endothelin 1. The gene discussed is TGFB1; the disease is chronic kidney disease.